Effective Date: August 15, 2017
Expiration Date: August 14, 2019
Format: Self Instructional - Audio Visual Voice-Over with Slides
Maximum Credits: .5 AMA PRA Category 1 CME Credit™(approved for American Board of Internal Medicine Maintenance of Certification (ABIM-MOC), .5 Nursing Contact Hours (.5 Pharmacotherapeutic Hours), .5 Pharmacy CE (Knowledge Based)
Estimated Completion Time: 0.5 hour
Funded through an educational grant from Portola Pharmaceuticals Inc.
This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to explain the incidence and sources of bleeding related to the use of oral anticoagulants and its impact on health care; compare the difference in bleeding risk between oral vitamin K antagonists and direct oral anticoagulants (DOACs) and be able to convert from one anticoagulant to another.
Case: A 57-year old Alaska Native female has been taking Warfarin for several years for non-valvular AF and wishes to switch to one of the newer DOACs, which she hears are safer.
This program is intended for primary care physicians, physician assistants, nurse practitioners, nurses, and other health care professionals interested in the treatment and management of patients at risk for stroke and working as a team for better patient outcomes.
There is no cost to participate in this program.
Upon completion of this CME/CE activity the healthcare provider will be able to:
Peter Kudenchuk, MD, FACP, FACC
Professor of Medicine
Division of Cardiology
University of Washington
Professor of Medicine in the Division of Cardiology at the University of Washington. Dr Kudenchuk is board certified in Internal Medicine, Cardiovascular Diseases, and Clinical Cardiac Electrophysiology. He has received numerous awards for excellence in teaching and clinical practice, and recognition as being among the “Best Doctors” in Seattle and in America. He has gained national attention through his publications and lecturing on heart failure and other coronary conditions.
FCM requires everyone who is in a position to control the content of a CE/CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by FCM.
Dr. Kudenchuk is a small family stock holder with Sanofi-Aventis, Johnson & Johnson and Pfizer.
Jeanette M. Dunn, EdD, RN, Lead Nurse Planner, Quality Control Officer, Lisa Chamberlain, Pharm D, have no financial interest in any of the products or manufacturers mentioned. Dr. Kudenchuk, content expert has and is a Small Family Stock holder with Sanofi-Aventis, Johnson & Johnson and Pfizer.
Accreditation Statement: The Foundation for Care Management (FCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for Physicians.
Designation Statement: FCM designates this educational activity for a maximum of .5 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of the participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .5 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program # 0347-0000-15-019-H01-P. All objectives are appropriate for pharmacists
* This CE activity is knowledge-based.
Accreditation Statement: The Foundation for Care Management is an approved provider of continuing nursing education by the Accredited by the Washington State Nurses Association WSNA A-CNE, an accredited approver of Continued Nursing Education.
View/Download Click Here (PDF file, link will open in new window)
To receive CME/CE credits, participants must review the program materials in their entirety and complete the online post examination and evaluation with a score of 70% or better. A statement of credit will be available for printing upon successful completion.
If you have questions about this CME/CE activity, please contact FCM at firstname.lastname@example.org.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.